SCHEMBL7414758

SCHEMBL7414758

O=C1c2c(c3ccccc3[nH]c2=O)C(=O)N1c1cccnc1

nearest known ligand 0.54

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.54
PARP1 P09874 5/20 0.48
GAA P10253 1/20 0.45
MAPT P10636 1/20 0.45
MAPK1 P28482 1/20 0.45
HSD17B10 Q99714 1/20 0.45
KDM4E B2RXH2 2/20 0.44
MAPK14 Q16539 2/20 0.44
ALOX5 P09917 1/20 0.44
PKM P14618 1/20 0.43
MAPK10 P53779 1/20 0.43
PADI4 Q9UM07 2/20 0.43
L3MBTL1 Q9Y468 2/20 0.42
AR P10275 1/20 0.42
CDK5 Q00535 1/20 0.41
CDK5R1 Q15078 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7409290 0.85 MAPK14 (0.53) PARP1MAPTHSD17B10KDM4EMAPK14
SCHEMBL7415475 0.84 MAPT (0.49) HTTPARP1GAAMAPTHSD17B10
SCHEMBL7412697 0.76 ADORA3 (0.51) PARP1GAAMAPTHSD17B10KDM4E
SCHEMBL7416744 0.76 PARP1 (0.49) PARP1GAAMAPTMAPK1HSD17B10
SCHEMBL7407990 0.76 MAPK14 (0.53) HTTPARP1GAAMAPTHSD17B10
SCHEMBL7415160 0.76 ADORA3 (0.54) GAAMAPTHSD17B10L3MBTL1
SCHEMBL7418663 0.76 ADORA3 (0.54) HTTPARP1GAAMAPTMAPK1
SCHEMBL7415495 0.74 KDM4E (0.40) PARP1MAPTHSD17B10KDM4EMAPK14
SCHEMBL7413449 0.74 ADORA3 (0.56) HTTGAAMAPTHSD17B10KDM4E
SCHEMBL7410394 0.73 ADORA3 (0.54) MAPTKDM4EPADI4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1994026741-A1 CERTAIN PYRROLOQUINOLINONES; A NEW CLASS OF GABE BRAIN RECEPTOR LIGANDS NEUROGEN CORPORATION (US) 1994-11-24 WO claimed
US-5243049-A Gamma-aminobutyric acid antagonist NEUROGEN CORPORATION (US) 1993-09-07 US claimed
US-5908932-A Certain pyrroloquinolinones; a new class of GABA brain receptor NEUROGEN CORPORATION (US) 1999-06-01 US disclosed
US-5604235-A DIAGNOSIS AND TREATMENT OF ANXIETY, SLEEP AND SEIZURE DISORDERS, BENZODIAZEPINE OVERDOSE; ENHANCEMENT OF MEMORY NEUROGEN CORPORATION (US) 1997-02-18 US disclosed
WO-1994026741-A1 CERTAIN PYRROLOQUINOLINONES; A NEW CLASS OF GABE BRAIN RECEPTOR LIGANDS NEUROGEN CORPORATION (US) 1994-11-24 WO disclosed
US-5243049-A Gamma-aminobutyric acid antagonist NEUROGEN CORPORATION (US) 1993-09-07 US disclosed